BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1381870)

  • 1. [Clinical evaluation of oral ofloxacin in 3-day therapy for transurethral resection of the prostate].
    Morita M; Ito S; Suzuki K
    Hinyokika Kiyo; 1992 Jul; 38(7):869-74. PubMed ID: 1381870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the long-term administration of ofloxacin to the patients following transurethral resection of the prostate].
    Morita M; Hasuda A; Suzuki K
    Hinyokika Kiyo; 1991 Jan; 37(1):99-103. PubMed ID: 1707218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibiotic prophylaxis for transurethral resection of the prostate--comparison of oral administration therapy with intravenous administration therapy].
    Tsuji Y; Okamura K; Miyake K; Ito H; Kinukawa T; Otani T; Narushima M; Kanai S; Takagi Y; Murase T
    Hinyokika Kiyo; 1993 Dec; 39(12):1145-52. PubMed ID: 7506866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.
    Wagenlehner FM; Wagenlehner C; Schinzel S; Naber KG;
    Eur Urol; 2005 Apr; 47(4):549-56. PubMed ID: 15774257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral ofloxacin versus intramuscular ceftriaxone in antibiotic prophylaxis in transurethral prostate resection].
    Botto H; Butreau-Lemaire M; Levy S; Delval C
    Prog Urol; 1993; 3(4):569-75. PubMed ID: 8401617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transurethral laser therapy and urinary tract infections.
    Miller J; Ludwig M; Schroeder-Printzen I; Schiefer HG; Weidner W
    Ann Urol (Paris); 1996; 30(3):131-8. PubMed ID: 8766150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of ciprofloxacine antibiotic prophylaxis of infectious complications after TUR of the prostate].
    Rafal'skiĭ VV; Strachunskiĭ LS; Kogan MI; Petrov SB; Grinev AV; Veliev EI; Kopylov VV; Iskorostinskiĭ EV; Kirekhin IV
    Urologiia; 2005; (5):21-5. PubMed ID: 16281834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotics in transurethral resection of the prostate in patients with low risk of infectious complications: randomized prospective comparative study].
    Valdevenito Sepúlveda JP
    Arch Esp Urol; 2004; 57(1):48-57. PubMed ID: 15112871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ofloxacin concentration in human benign prostatic tissue after oral administration.
    Asakawa M; Yasumoto R
    Hinyokika Kiyo; 1988 Jun; 34(6):1097-9. PubMed ID: 2464915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy after prostatectomy--effects of long term administration of Pivmecillinam (PMPC)].
    Sagawa S; Takaha M; Sonoda T; Shin T; Yano H; Mizutani S; Sakurai T; Kotake T; Nakamura T; Nagano S
    Hinyokika Kiyo; 1984 Mar; 30(3):423-30. PubMed ID: 6205570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
    Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
    Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic prophylaxis for patients undergoing transurethral resection of the prostate.
    Hall JC; Christiansen KJ; England P; Low AI; McRae PJ; Mander J; Taylor TA; Hall JL
    Urology; 1996 Jun; 47(6):852-6. PubMed ID: 8677576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy].
    Yang L; Hu J; Wei H; Wang L; Zhong H
    Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):940-2. PubMed ID: 16201177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime in transurethral prostatectomy.
    Fujita K; Murayama T
    Clin Ther; 1988; 10 Spec No():43-6. PubMed ID: 3233629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preventive chemotherapy after transurethral prostatectomy: a randomized study].
    Yoshida O; Arai Y; Takeuchi H; Fukuyama T; Hida S; Ikeda T; Okabe T; Kuo SY; Kounami T; Nakagawa T
    Hinyokika Kiyo; 1993 May; 39(5):491-6. PubMed ID: 7686715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and prostatic tissue concentrations of ofloxacin.
    Fujita K; Munakata A
    Clin Ther; 1988; 10 Spec No():32-5. PubMed ID: 3233627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic and chemotherapeutic efficacy of pivmecillinam (PMPC) against infections after TUR-P and prostatectomy].
    Maru A; Mitsuhashi K; Shiba T; Ohashi N; Fujieda J; Nishida T; Okoshi R; Kusakai Y; Amino I; Kaneda T
    Hinyokika Kiyo; 1983 Feb; 29(2):245-53. PubMed ID: 6203380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single prophylactic dose of ceftriaxone as total antibiotic therapy in transurethral surgery.
    Finkelstein LH
    J Am Osteopath Assoc; 1989 Feb; 89(2):169-70. PubMed ID: 2925456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.